Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Feinglos

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Diabetes Reports|November 2, 2006
Are sulfonylureas passé?Jennifer B Green, Mark N Feinglos
Current Diabetes Reports|March 20, 2003
Insulin analogues: new therapies for type 2 diabetes mellitusM Angelyn Bethel, Mark N Feinglos
Archives of Internal Medicine|July 30, 2008
Are you what you eat, or how much you eat? The case of type 2 diabetes mellitusMark N Feinglos, Susan E Totten
Cleveland Clinic Journal of Medicine|October 1, 2005
Emerging care for type 2 diabetes: using insulin to reach lower glycemic goalsMark N Feinglos, M Angelyn Bethel
Current Diabetes Reports|January 5, 2008
Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesityJennifer B Green, Mark N Feinglos
Current Diabetes Reports|March 21, 2013
Risk vs benefit in diabetes pharmacotherapy: a rational approach to choosing pharmacotherapy in type 2 diabetesMary Elizabeth Cox, Mark N Feinglos
Drug Safety|March 1, 2005
Protease inhibitor-induced diabetic complications : incidence, management and preventionLillian F Lien, Mark N Feinglos
The Journal of the American Board of Family Practice|May 10, 2005
Basal insulin therapy in type 2 diabetesM Angelyn Bethel, Mark N Feinglos
Postgraduate Medicine|July 31, 2009
Algorithm: management of diabetes mellitus: dietary and drug therapyJessica Shill, M Angelyn Bethel, Mark N Feinglos
Postgraduate Medicine|July 31, 2009
Algorithm: management of diabetes mellitusJessica Shill, M Angelyn Bethel, Mark N Feinglos
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Diabetes Reports|November 2, 2006
Are sulfonylureas passé?Jennifer B Green, Mark N Feinglos
Current Diabetes Reports|March 20, 2003
Insulin analogues: new therapies for type 2 diabetes mellitusM Angelyn Bethel, Mark N Feinglos
Archives of Internal Medicine|July 30, 2008
Are you what you eat, or how much you eat? The case of type 2 diabetes mellitusMark N Feinglos, Susan E Totten
Cleveland Clinic Journal of Medicine|October 1, 2005
Emerging care for type 2 diabetes: using insulin to reach lower glycemic goalsMark N Feinglos, M Angelyn Bethel
Current Diabetes Reports|January 5, 2008
Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesityJennifer B Green, Mark N Feinglos
Current Diabetes Reports|March 21, 2013
Risk vs benefit in diabetes pharmacotherapy: a rational approach to choosing pharmacotherapy in type 2 diabetesMary Elizabeth Cox, Mark N Feinglos
Drug Safety|March 1, 2005
Protease inhibitor-induced diabetic complications : incidence, management and preventionLillian F Lien, Mark N Feinglos
The Journal of the American Board of Family Practice|May 10, 2005
Basal insulin therapy in type 2 diabetesM Angelyn Bethel, Mark N Feinglos
Postgraduate Medicine|July 31, 2009
Algorithm: management of diabetes mellitus: dietary and drug therapyJessica Shill, M Angelyn Bethel, Mark N Feinglos
Postgraduate Medicine|July 31, 2009
Algorithm: management of diabetes mellitusJessica Shill, M Angelyn Bethel, Mark N Feinglos
Pageof 5